Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement-Reference-Cited by-同舟云学术

Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement

Published:2014-05 Issue:5 Volume:3 Page:146-149
ISSN:2046-3758
Container-title:Bone & Joint Research
language:en
Short-container-title:Bone & Joint Research

Author:

Jameson S. S.¹,Baker P. N.¹,Deehan D. J.²,Port A.¹,Reed M. R.³

Affiliation:

1. South Tees Hospitals NHS Foundation Trust, Marton Road, Middlesbrough TS4 3BW, UK.

2. Newcastle Hospitals NHS Foundation Trust, Freeman Road, High Heaton, Newcastle upon Tyne, NE7 7DN, UK.

3. Northumbria Healthcare NHS Foundation Trust, Woodhorn Lane, Ashington, NE63 9JJ, UK.

Abstract

The National Institute for Health and Clinical Excellence (NICE) has thus far relied on historical data and predominantly industry-sponsored trials to provide evidence for venous thromboembolic (VTE) prophylaxis in joint replacement patients. We argue that the NICE guidelines may be reliant on assumptions that are in need of revision. Following the publication of large scale, independent observational studies showing little difference between low-molecular-weight heparins and aspirin, and recent changes to the guidance provided by other international bodies, should NICE reconsider their recommendations? Cite this article: Bone Joint Res 2014;3:146–9.

Publisher

British Editorial Society of Bone & Joint Surgery

Subject

Orthopedics and Sports Medicine,Surgery

Link

https://online.boneandjoint.org.uk/doi/pdf/10.1302/2046-3758.35.2000225

Reference42 articles.

1. Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study

2. No authors listed. National Joint Registry for England and Wales: 8th Annual Report, 2011. http://www.njrcentre.org.uk/NjrCentre/LinkClick.aspx?fileticket=1TQ%2bEiNejm0%3d& tabid=86& mid=523 (date last accessed 30 October 2013).

3. No authors listed. National Institute for Health and Clinical Excellence: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital http://www.nice.org.uk/nicemedia/live/12695/47920/47920.pdf (date last accessed 17 April 2014).

4. No authors listed. Surveillance of Surgical Site Infections in NHS Hospitals in England: Health Protection Agency. 2012. http://www.hpa.org.uk (date last accessed 17 April 2014).

5. Enhanced recovery program for hip and knee replacement reduces death rate

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis;Cureus;2023-03-21

2. Current status survey of the extramural hospital management of venous thromboembolism after total hip and knee arthroplasty in China;BMC Musculoskeletal Disorders;2021-09-13

3. The Incidence of Venous Thromboembolism in Patients Undergoing Anterior Lumbar Interbody Fusion: A Proposed Thromboprophylactic Regime;International Journal of Spine Surgery;2021-04

4. Interplay between platelets and coagulation;Blood Reviews;2021-03

5. Venous thromboembolism prevention protocol for adapting prophylaxis recommendations to the potential risk post total knee replacement: a randomized controlled trial;Pharmacy Practice;2020-09-22